Sonova Holding (OTCMKTS:SONVY) Short Interest Update

Sonova Holding (OTCMKTS:SONVYGet Free Report) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totaling 72,798 shares, an increase of 3,416.8% from the April 30th total of 2,070 shares. Based on an average daily trading volume, of 84,663 shares, the short-interest ratio is currently 0.9 days. Approximately 0.0% of the shares of the company are sold short.

Sonova Stock Up 0.8%

Shares of SONVY stock opened at $53.38 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91. Sonova has a 52-week low of $42.26 and a 52-week high of $63.69. The company’s 50 day moving average is $46.39 and its 200 day moving average is $49.92.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Citigroup reissued a “sell” rating on shares of Sonova in a research note on Wednesday, May 13th. BNP Paribas Exane upgraded Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a report on Monday, February 9th. Finally, Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, March 18th. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Sonova presently has a consensus rating of “Hold”.

Check Out Our Latest Stock Report on Sonova

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Recommended Stories

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.